Could modified heparin promote myelin repair?
Lead researcher: Professor Sue Barnett
Based at: University of Glasgow
Grant we awarded: £150,362
Researchers have discovered that myelin repair can be boosted in the lab using a modified version of the blood thinning drug heparin. It could also help to protect nerves from damage.
What happens in this project?
Our scientists will investigate the potential benefits of modified heparin in animal model of MS. They also compare the benefits of giving the drug orally or as an injection.
How will it help people with MS?
If modified heparin can myelin repair and protect nerves from damage in mice then it can be tested as a treatment for all forms of MS.
Because other forms of heparin have safely been used as medicines for many years it could go through clinical trials more quickly than other drugs.
The difference you can make
There are currently no treatments available to help repair damage caused by MS. We need to support innovative research like this if treatments are to be reality.
The next research breakthrough is in reach
Your donation will help stop MS.
£30could process one blood sample, giving researchers crucial information about genes and the immune system.
£50could pay for an hour on a microscope, so scientists can study cells and tissue in greater detail and improve their understanding of the biology of MS.
£100could pay for half an hour of MRI use, so researchers can monitor the success of clinical trials and understand MS in more detail.
Every penny you give really does take us a step closer to stopping MS. Your donation will make a difference.
£10a month could pay for lab equipment like microscope slides to study the building blocks of MS
£20a month could pay for lab equipment like petri dishes to grow bacteria important for studying genetics
£30a month could process a blood sample to help us understand what causes MS, so we can stop it in its tracks
Your regular donation means we can keep funding world class MS research with confidence. Together we will stop MS.